ALEC
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Sector:
Industry:
Short Interest ():
Ethical Flags
Longest drawdown: 3 trading days
From: 2019-02-07 To: 2019-02-12
Lowest Point:
U.S. IPO Weekly Recap: 2 Billion-Dollar Biotechs Cap A Mixed Week For Biotech IPOs
via: SeekingAlpha at 2019-02-09 11:13:47:000
In the second week after the SEC opened, we saw a number of launches and two billion-dollar biotechs, Alector (ALEC) and Gossamer Bio (GOSS), price their IPOs. Another biotech, Harpoon Therapeutics (HARP), along with three SPACs, also priced their IPOs. Alector, a Phase 1 biotech developing … read more...
U.S. IPO Weekly Recap: 2 Billion-Dollar Biotechs Cap A Mixed Week For Biotech IPOs
via: SeekingAlpha at 2019-02-09 11:13:47:000
In the second week after the SEC opened, we saw a number of launches and two billion-dollar biotechs, Alector (ALEC) and Gossamer Bio (GOSS), price their IPOs. Another biotech, Harpoon Therapeutics (HARP), along with three SPACs, also priced their IPOs. Alector, a Phase 1 biotech developing … read more...
U.S. IPO Weekly Recap: 2 Billion-Dollar Biotechs Cap A Mixed Week For Biotech IPOs
via: SeekingAlpha at 2019-02-09 11:13:47:000
In the second week after the SEC opened, we saw a number of launches and two billion-dollar biotechs, Alector (ALEC) and Gossamer Bio (GOSS), price their IPOs. Another biotech, Harpoon Therapeutics (HARP), along with three SPACs, also priced their IPOs. Alector, a Phase 1 biotech developing … read more...
U.S. IPO Weekly Recap: 2 Billion-Dollar Biotechs Cap A Mixed Week For Biotech IPOs
via: SeekingAlpha at 2019-02-09 11:13:47:000
In the second week after the SEC opened, we saw a number of launches and two billion-dollar biotechs, Alector (ALEC) and Gossamer Bio (GOSS), price their IPOs. Another biotech, Harpoon Therapeutics (HARP), along with three SPACs, also priced their IPOs. Alector, a Phase 1 biotech developing … read more...
Alector prices IPO at $19
via: SeekingAlpha at 2019-02-07 02:40:03:000
Alector (NASDAQ: ALEC ) prices its IPO of 9.25M shares of common stock at $19.00/share, for expected gross proceeds of $176M. More news on: Alector, Inc., Healthcare stocks news, Read more … read more...
Alector prices IPO at $19
via: SeekingAlpha at 2019-02-07 02:40:03:000
Alector (NASDAQ: ALEC ) prices its IPO of 9.25M shares of common stock at $19.00/share, for expected gross proceeds of $176M. More news on: Alector, Inc., Healthcare stocks news, Read more … read more...
Alector Announces Pricing of Initial Public Offering
via: Business Wire at 2019-02-06 19:59:00:000
Alector, Inc. (Nasdaq: ALEC), a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration, today announced the pricing of its initial public offering of 9,250,000 shares of common stock to the public at $19.00 per sh… read more...
Alector Announces Pricing of Initial Public Offering
via: Business Wire at 2019-02-06 19:59:00:000
Alector, Inc. (Nasdaq: ALEC), a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration, today announced the pricing of its initial public offering of 9,250,000 shares of common stock to the public at $19.00 per sh… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|